How can we monitor Dabigatran effects ? Dabigatran, like argatroban, does prolong the prothrombin time (PT) and partial thromboplastin time (PTT). It also prolongs the thrombin time (TT), which means it generates a false decrease in fibrinogen assay results, given that the fibrinogen assay is based on the TT. Dabigatran’s plasma concentration peaks about two […]
and the winner is…. I extrapolated 220.000 € to Spanish projects while 100.000 to Italy, Romania, Belg… Paris, France and Ingelheim, Germany, 29th August 2011 – Last night at an award ceremony in Paris, the 32 winning projects of the global disease awareness initiative 1 Mission 1 Million – Getting to the Heart of […]
finally the expert panel delivered the list of projects for step 2. Public vote will start, if the schedule will not change, after march 22nd. https://www.heartofstroke.com/1-mission-1-million our project passed the screening of the experts see at the link provided not yet activated by the system https://www.heartofstroke.com/spaces
on 30 August 2010 Ingelheim, Germany – Report: The European Society of Cardiology (ESC) today issued a revised version of guidelines for the management of atrial fibrillation (AF), including guidance on the role of thge new oral treatment, dabigatran etexilate, for the prevention of embolism in patients with atrial fibrillation (AF). At the same time, […]
What is 1 Mission 1 Million? 1 Mission 1 Million is a new global campaign to raise awareness of atrial fibrillation and its link to stroke. €1 million is available to fund community-driven projects, chosen by you, that take action against atrial fibrillation-related stroke by contributing to this goal. Play your part by submitting a […]
strokefocus 